Cost-effectiveness of cabozantinib for patients with advanced renal cell carcinoma after failure of prior Therapy in South Korea

Author

Kim S, Han S, Kim H, and Suh HS

Journal

The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress

Remarks

Barcelona, Spain. November 2018.